- Home
- ATAI vs ISPR Comparison
ATAI vs ISPR Comparison
Compare ATAI & ISPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- ISPR
- Stock Information
- Founded
- ATAI 2018
- ISPR 2010
- Country
- ATAI Netherlands
- ISPR United States
- Employees
- ATAI N/A
- ISPR N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- ISPR Medicinal Chemicals and Botanical Products
- Sector
- ATAI Health Care
- ISPR Health Care
- Exchange
- ATAI Nasdaq
- ISPR Nasdaq
- Market Cap
- ATAI 1.6B
- ISPR 126.0M
- IPO Year
- ATAI 2021
- ISPR 2023
- Fundamental
- Price
- ATAI $4.34
- ISPR $1.53
- Analyst Decision
- ATAI Strong Buy
- ISPR Strong Buy
- Analyst Count
- ATAI 5
- ISPR 1
- Target Price
- ATAI $14.00
- ISPR $7.50
- AVG Volume (30 Days)
- ATAI 7.6M
- ISPR 46.6K
- Earning Date
- ATAI 11-14-2025
- ISPR 11-06-2025
- Dividend Yield
- ATAI N/A
- ISPR N/A
- EPS Growth
- ATAI N/A
- ISPR N/A
- EPS
- ATAI N/A
- ISPR N/A
- Revenue
- ATAI $2,309,000.00
- ISPR $118,506,875.00
- Revenue This Year
- ATAI $736.04
- ISPR $60.96
- Revenue Next Year
- ATAI N/A
- ISPR $23.96
- P/E Ratio
- ATAI N/A
- ISPR N/A
- Revenue Growth
- ATAI 510.85
- ISPR N/A
- 52 Week Low
- ATAI $1.15
- ISPR $1.49
- 52 Week High
- ATAI $6.75
- ISPR $7.47
- Technical
- Relative Strength Index (RSI)
- ATAI 33.90
- ISPR 29.20
- Support Level
- ATAI $4.14
- ISPR $2.31
- Resistance Level
- ATAI $5.91
- ISPR $1.99
- Average True Range (ATR)
- ATAI 0.38
- ISPR 0.22
- MACD
- ATAI -0.23
- ISPR -0.06
- Stochastic Oscillator
- ATAI 6.82
- ISPR 1.92
About ATAI ATAI Life Sciences N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping products in the United States, Europe, Canada, and South Africa. Geographically, the company generates the majority of its revenue from Europe.